Company: QXO-PB
Filing Date: 2025-05-22
Form Type: 424B5
Source: 0001104659-25-052056
Chunk: 0

Company: QXO, Inc.
Filing Date: 2025-05-22
Form: 424B5
Chunk 0
---
TABLE OF CONTENTS

Filed Pursuant to Rule 424(b)(5)
Registration No. 333-281084 PROSPECTUS SUPPLEMENT
(To Prospectus dated July 29, 2024) 48,484,849 Shares Common Stock QXO, Inc. is offering 48,484,849 shares of its common stock, par value $0.00001 per share (“Common Stock”), pursuant to this prospectus supplement and the accompanying prospectus. Concurrently with this offering, we are also making a public offering of 10,000,000 depositary shares (the “Depositary Shares”), each of which represents a 1/20th interest in a share of our 5.50% Series B Mandatory Convertible Preferred Stock, par value $0.001 per share (the “Mandatory Convertible Preferred Stock”), pursuant to a separate prospectus supplement (the “Depositary Shares Offering”). We have granted the underwriters of the Depositary Shares Offering a 30-day option to purchase up to 1,500,000 additional Depositary Shares, solely to cover over-allotments, if any. The closing of this offering is not conditioned upon the closing of the Depositary Shares Offering, and the closing of the Depositary Shares Offering is not conditioned upon the closing of this offering, so it is possible that this offering occurs and the Depositary Shares Offering does not occur, or vice versa. We cannot assure you that the Depositary Shares Offering will be completed on the terms described herein, or at all. Nothing contained herein shall constitute an offer to sell or a solicitation of an offer to buy any of the Depositary Shares or the Mandatory Convertible Preferred Stock being offered in the Depositary Shares Offering. See the section titled “Concurrent Depositary Shares Offering.” We intend to use the net proceeds of this offering, together with the net proceeds of the Depositary Shares Offering, if completed, to repay indebtedness under our Term Loan Facility (as defined herein), which will strengthen our position with respect to future acquisition opportunities. See “Use of Proceeds.” Our Common Stock is listed on the New York Stock Exchange (“NYSE”) under the symbol “QXO.” On May 21, 2025, the last reported sale price of our Common Stock on the NYSE was $17.06 per share. See “Risk Factors” beginning on page S-13of this prospectus supplement and in the documents incorporated by reference in this prospectus supplement to read about factors you should